Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious honors for product innovation at the 38th annual Edison Awards.

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced...

Medical device manufacturer medi® USA announced the launch of the Norton Hand Solution – nighttime, an innovative, patented custom device designed to help persistent hand swelling, firm fibrosis and quick-refill symptoms....

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its second fiscal...

On July 30, 2025, Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), announced a strategic collaboration to an...

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on July 31, 2025, the Compensation Committee of...

The American Pharmacists Association (APhA) is deeply concerned with the Advisory Committee on Immunization Practices (ACIP) Secretariat's decision to label Liaison organizations as a "special interest groups" and...

Zenara Pharma Private Limited ("Zenara"), a Biophore company, today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for...

BioLab Holdings, Inc., a Phoenix-based medical manufacturer specializing in regenerative wound care, has initiated its most comprehensive clinical trial to date. The multicenter, prospective, randomized controlled study...

Avanos Medical, Inc. (NYSE: AVNS), announced today the divestiture of its Hyaluronic Acid (HA) product line to Channel-Markers Medical, LLC (CMM), a privately held company based in Raleigh, NC.

Amgen (NASDAQ:AMGN) today announced that it will report its second quarter 2025 financial results on Tuesday, August 5, 2025, after the close of the U.S. financial markets. The announcement will be followed by a conference...

IMV, a Science and Medicine Group company, a leading provider of market intelligence for the medical imaging industry, has published the 2025 Ultrasound Market Outlook Report, providing decision-makers with in-depth...

Azurity Pharmaceuticals, Inc. announced today the availability of BRYNOVIN™ (sitagliptin) oral solution, a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control...

Proximal junctional kyphosis (PJK) and failure (PJF) remain the bane of spinal deformity surgeons' existence.  While many methods (i.e. tether, cement augmentation, "ideal" alignment) have been proposed to decrease...

BayCare Health System, West Central Florida's leading, not-for-profit, community-based academic health care system, has received the 2025 Pharmacy Compounding Excellence Award from Premier, Inc., a leading...

Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its second quarter 2025 financial...

AEYE Health, the leader in AI-powered retinal diagnostics, announces the appointment of Dr. Pamela F. Gallin as its Chief Medical Officer. A highly reputable and renowned ophthalmologist, Dr. Gallin brings decades of...

OneOncology, a physician-led national platform empowering independent oncology practices, is pleased to announce that Ian Wong has been appointed Chief Operating Officer (COO).

Mezzion Pharmaceuticals, Inc. (Mezzion) announced that its confirmatory Phase 3 FUEL-2 study evaluating JURVIGO® (udenafil)1 in adolescents and young adults with Fontan circulation has surpassed a key enrollment milestone...

AbbVie (NYSE:ABBV) announced financial results for the second quarter ended June 30, 2025.

Sound Blade Medical, Inc., a leader in handheld histotripsy therapy, today announced the appointment of Neil Barman, M.D. as Chief Executive Officer. Dr. Barman, a physician-executive with more than two decades of medical...

Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in oncology, inflammation and immunology (I&I), today announced the appointment of Mikael...

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, highlights new studies that demonstrate the vital...

Indivior PLC (Nasdaq: INDV) today reported its financial results for the second quarter ended June 30, 2025, and provided a business update.

PreludeDx™, a leader in breast cancer precision diagnostics, today announced the publication of new groundbreaking data in the International Journal of Radiation Oncology• Biology• Physics ("Red Journal").

CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended June 30, 2025.

This acquisition enables ESTEVE CDMO (Esteve Química) to expand its contract development and manufacturing services for small-molecule active pharmaceutical ingredients from pre-clinical to commercial manufacturing in the US.

Joseph Spine Institute is proud to announce that its founder, Dr. Samuel A. Joseph, Jr., has once again been named one of America's Top 150 Spine Surgeons by Newsweek - earning this prestigious national distinction in...

OMRON Healthcare Co., Ltd., the world's leading manufacturer and distributor of personal heart health products, has successfully concluded a three-month study demonstrating how remotely monitored vital signs can...

Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the second quarter ended June 30, 2025, and updated its 2025 financial guidance.

FuturHealth, a leading provider of personalized weight-loss solutions, today announced it is giving its members seamless access to FDA-approved GLP-1 medications - including Wegovy® - at highly affordable, cash-pay prices,...

Gnosis, a Southern California-based diagnostic lab advancing women's health through molecular innovation, today announced the national launch of EdenDx, which stands for Early Detection for Endometrial Neoplasia, the...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that the two-year...

Alafair Biosciences, a medical device company redefining soft-tissue protection in orthopedic surgery, announced today that it has received two 510(k) clearances from the FDA for VersaCoat™ Tendon Protector and VersaCoat™...

Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Nature featuring groundbreaking preclinical data for the treatment of hepatocellular...

At ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), new research spotlights two tests that could revolutionize women's healthcare. One study showed that a self-collection test for human...

Breaking research presented today at ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) found that people who live in areas with higher levels of PFAS in their drinking water also have elevated...

The American Society of Transplant Surgeons (ASTS) and American Society of Transplantation (AST) announced today that the Transplant Therapeutics Consortium (TTC) received notification from FDA of the Reviewability of the...

Veloxis Pharmaceuticals, Inc. (Veloxis), an Asahi Kasei company and a global specialty pharmaceutical company, is pleased to announce it will present new preclinical data at the upcoming World Transplant Congress (WTC) on...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai")  and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that results on...

Expanding the use of Alzheimer's blood tests is crucial to usher in a new era of precision medicine and bring Alzheimer's disease into mainstream care. The new clinical practice guidelines for blood biomarkers...

CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, today announced that the 100th patient has received treatment for communicating hydrocephalus with the eShunt...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the Canadian Intellectual Property Office (CIPO) has issued...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that the latest findings...

MyHealthTeam, a Swoop company, the creator of one of the largest, engaged patient social networks in healthcare, has announced the launch of myMDteam. This new website and patient community is dedicated to those diagnosed...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it will host a business...

Eli Lilly and Company (NYSE: LLY) announced results from the long-term extension (LTE) of the Phase 3 TRAILBLAZER-ALZ 2 study showing that participants treated with Kisunla (donanemab-azbt) demonstrated slowing of decline,...

With rising healthcare costs and pharmacy benefit manager (PBM) practices at the forefront of national conversation, Imagine360, a leading alternative health plan for self-funded employers, has launched Complete Care to...

PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it had...

Gnosis, a Southern California-based diagnostic lab advancing women's health through molecular innovation, today announced the national launch of EdenDx, which stands for Early Detection for Endometrial Neoplasia, the...

Orsini, a leader in rare disease pharmacy solutions, has been chosen by PTC Therapeutics as a specialty pharmacy partner for SEPHIENCE™ (sepiapterin), an FDA-approved oral therapy indicated for the treatment of...

Immunitas Therapeutics ("Immunitas"), a clinical stage precision immunotherapy company committed to discovering and developing novel, antibody-based therapeutics for patients with autoimmune diseases and cancer, today...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Test Finder, a first-of-its-kind generative AI tool developed with Amazon Web Services (AWS). Designed...

Cardinal Health (NYSE:CAH) announced today the expansion of Equity Rx, to help meet the needs of people across Ohio and beyond who cannot afford their prescription medications. Launched as a pilot in Ohio in 2023, Equity...

LCP Health Analytics is partnering with COTA to explore how US real-world data (RWD) can support health technology assessments (HTA) in the United Kingdom (UK) and European Union (EU). With growing recognition that...

Kedrion Biopharma is proud to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Coagulation Factor X human (tradename COAGADEX) for the treatment of acquired Factor X...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the second quarter 2025 following the close of market...

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of...

Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it will...

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report second quarter 2025 financial results on Thursday, August 7,...

Equity Insider News Commentary – The average age of cancer patients is getting younger, as experts are urgently examining the rise of early-onset incidence across several different cancer types. According to the Cancer...

BlueSphere Bio, a clinical stage drug development company focused on novel T cell based therapies, today announced its Chief Scientific Officer, Alan Korman, Ph.D. is the 2025 recipient of one of the Cancer Research...

Equity Insider News Commentary – There's a lot of big voices pushing for the AI revolution to make its mark, including a new plan from the U.S. Department of Commerce to address slow-to-adopt sectors like healthcare....

In a landmark step toward transforming Alzheimer's disease diagnosis in specialty care, the Alzheimer's Association today released its first clinical practice guideline (CPG) on the use of blood-based biomarker...

Magnolia Medical Technologies, Inc., the inventor of the Steripath® Initial Specimen Diversion Device® platform, today announced the appointment of Jason Richey as President and Chief Executive Officer, as well as a member...

Kaiser Permanente, one of America's leading health care organizations and nonprofit health plans, has announced that 38 of its 40 hospitals received recognition from U.S. News & World Report in its annual hospital...

The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is pleased to announce the recipients of its 2025 Top Corporate Supporter Award, a distinction given to companies and organizations that...

Hohenstein Medical, a division of Hohenstein Laboratories, announced it is now certified to conduct medical device testing in accordance with the internationally recognized Good Laboratory Practice (GLP) standard. The...

Panome Bio, a leader in advanced proteomic, metabolomic and transcriptional profiling technologies, announced it has achieved Clinical Laboratory Improvement Amendments (CLIA) certification for its state-of-the-art...

Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its next-generation InThrill Thrombectomy System, the first and only purpose-built small vessel and...

Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleukin for the treatment of severe-to-very severe alopecia areata (AA)...

The National Association of Corporate Directors® (NACD®), the authority on boardroom practices representing more than 24,000 board members, today released the 2025 Public Company Board Practices and Oversight Survey...

Vexev, an Australian-based medical device company advancing next-generation vascular imaging, and U.S. Renal Care, a leading provider of in-center and home dialysis in the United States, today announced the successful...

Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that the Company will host a...

Leading patient engagement technology provider SONIFI Health has announced the addition of Jared Allen to its leadership team as the company's senior vice president of healthcare sales.

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its second quarter 2025 financial results after market close on Tuesday, August 5, 2025. Rigel senior management will follow the announcement...

Quasar Medical, a global leader in manufacturing interventional and minimally invasive medical devices, announced today the opening of its Global Headquarters in Singapore. This milestone marks the company's continued...

Johnson & Johnson (NYSE: JNJ) – Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, today announced the launch of the VIRTUGUIDE™ System. This AI-powered, patient-matched solution...

MDpanel is happy to announce a strategic combination with Integra Medical Consulting (Integra), a highly respected independent medical evaluation (IME) provider based in Vancouver, British Columbia. This milestone marks...

Healthcare industry veterans Kelly Franchetti and Jennifer McAleer have announced the launch of The Patient View, a company dedicated to integrating patient perspectives into clinical trials, patient services, and...

ClariMed, Inc., a global leader in human-centered medical device development and regulatory services, today announced it has achieved ISO 13485:2016 certification through BSI, marking a significant milestone in the...

Johnson & Johnson (NYSE: JNJ) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval to include new evidence in the...

Atossa Therapeutics, Inc. (NASDAQ: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines in oncology, today announced positive written feedback from the U.S. Food and Drug Administration (FDA)...

Hardy Diagnostics is pleased to announce the FDA clearance of the NG-TEST® CTX-M Multi, an in vitro, rapid, and visual immunoassay for the qualitative detection of most prevalent CTX-M enzymes (groups 1, 2, 8, 9, and 25)...

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report second quarter 2025 financial results...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today PGDx elio™ tissue complete has been CE-marked under the European Union's (EU) new In Vitro Diagnostic Regulation...

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 BRUIN CLL-314 clinical trial of Jaypirca (pirtobrutinib), a non-covalent (reversible) Bruton's tyrosine kinase (BTK)...

Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11...

In honor of World Lung Cancer Day on Friday, August 1, the American Lung Association, in partnership with Olympus, is launching a new educational campaign about lung nodules. The campaign is shaped by the voices of people...

Hackensack Meridian Health, New Jersey's largest and most comprehensive hospital network, is proud to announce that U.S. News & World Report named Hackensack University Medical Center the #1 hospital in the New...

Kinvard Bio Inc., a biotechnology company pioneering a next-generation class of broad-spectrum antibiotics, today announced it has been awarded US$2.7 million follow-on non-dilutive funding from CARB-X (Combating...